Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) Sees Significant Increase in Short Interest

Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) was the recipient of a significant increase in short interest in the month of October. As of October 30th, there was short interest totaling 1,324 shares, an increase of 586.0% from the October 15th total of 193 shares. Approximately 0.0% of the shares of the stock are short sold. Based on an average daily volume of 8,514 shares, the short-interest ratio is presently 0.2 days.

Institutional Investors Weigh In On Oaktree Acquisition Corp. III Life Sciences

Hedge funds have recently bought and sold shares of the company. Periscope Capital Inc. acquired a new position in shares of Oaktree Acquisition Corp. III Life Sciences in the 3rd quarter valued at $3,488,000. Rangeley Capital LLC increased its position in shares of Oaktree Acquisition Corp. III Life Sciences by 52.8% in the 1st quarter. Rangeley Capital LLC now owns 61,188 shares of the company’s stock valued at $647,000 after buying an additional 21,156 shares in the last quarter. Finally, DLD Asset Management LP raised its stake in Oaktree Acquisition Corp. III Life Sciences by 0.9% during the 1st quarter. DLD Asset Management LP now owns 136,735 shares of the company’s stock worth $1,447,000 after buying an additional 1,200 shares during the period.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings upgraded shares of Oaktree Acquisition Corp. III Life Sciences from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Friday, October 2nd. One investment analyst has rated the stock with a Hold rating. Based on data from MarketBeat, Oaktree Acquisition Corp. III Life Sciences presently has a consensus rating of “Hold”.

Oaktree Acquisition Corp. III Life Sciences Trading Up 0.1%

NASDAQ OACC opened at $10.71 on Wednesday. The stock has a 50-day simple moving average of $10.74 and a 200 day simple moving average of $10.70. Oaktree Acquisition Corp. III Life Sciences has a 12 month low of $10.50 and a 12 month high of $10.93.

Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) last issued its quarterly earnings data on Wednesday, August 12th. The company reported $0.07 earnings per share (EPS) for the quarter.

Oaktree Acquisition Corp. III Life Sciences Company Profile

Oaktree Acquisition Corp. III Life Sciences is a special purpose acquisition company (SPAC) formed to identify and complete a business combination with a company in the life sciences sector. The company does not operate as a traditional life sciences manufacturer or service provider and does not currently market its own products. Its stated focus includes potential merger or acquisition opportunities involving pharmaceutical, biotechnology, medical device, diagnostics, and other healthcare-related businesses.